ClinicalTrials.gg
CompletedNCT06768021Updated Apr 30, 2026

Does Style of Pre-sedation Instructions Improve Patient Outcomes in Ambulatory Anesthesia for Oral and Maxillofacial Surgery?

An interventional study of Guided visualization and standardized pre-sedation instructions and Standardized pre-sedation instructions only in Anesthesia Outcomes, Anesthesia Complication and Anesthesia and Procedure Related Time Intervals, sponsored by Alameda Health System. Completed at 1 site in United States. Open to participants aged 8 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-04-30.

Primary conditionMotor Activity(the registry's first term)UnverifiedIs this wrong?Motor Activity is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Alameda Health System · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
8 Years to 70 Years
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the impact of a brief guided visualization exercise on anesthesia-related outcomes in oral and maxillofacial surgery in patients scheduled for ambulatory anesthesia in the oral and maxillofacial surgery clinic. Researchers will compare these patients, who will receive the guided visualization exercise in addition to standardized pre-operative instructions, to patients who will only receive the standardized pre-operative instructions. The following outcomes will be measured for both groups:

  • A seven-point Anesthesia Experience Survey
  • Face-Legs-Activity-Cry-Consolability (FLACC) scores at three points in time during the anesthetic - during local anesthesia, during surgery, and fifteen minutes after surgery has concluded
  • Amount of medications used during the sedation
  • Length of sedation
02

Conditions studied

  • Anesthesia Outcomes
  • Anesthesia Complication
  • Anesthesia and Procedure Related Time Intervals
  • Anesthesia Recovery Period
  • Anesthesia, Intravenous
  • Anesthesia Induction

Browse trials for

Keywords

  • Anesthesia Experience Survey
  • Ambulatory anesthesia
  • Intravenous sedation
  • Guided Visualization
  • Pre-sedation instructions
  • Anesthesia outcomes
  • Oral & Maxillofacial Surgery (OMFS)
  • Face, Legs, Activity, Cry, Consolability (FLACC)
03

In context

Motor Activity Unverified

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's enrollment of 128 is above the median of 60 across 8,388 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Alameda Health System is the lead sponsor of 4 studies on the registry; none are open to participants now.

Compared within Motor Activity, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
8 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects within ages 8 to 70.
  • Subjects planned for ambulatory intravenous sedation in the oral and maxillofacial surgery clinic.
  • Ability to understand verbal English or understand instructions using a sign-language or voice interpreter of their native language.

Exclusion criteria

Exclusion Criteria:

  • Subjects who cannot understand the instructions, even with an interpreter (extremes of age, cognitive impairments, severe psychiatric disease that may affect participation)
  • Subjects not undergoing intravenous sedation (oral sedation, nitrous oxide, local anesthesia)
  • Subjects undergoing anesthesia in other environments (gastrointestinal suite, operating rooms, interventional radiology)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
128 participants (actual)

Study arms

  • Placebo comparator
    Standardized pre-sedation instructions only group

    This group will receive the standardized pre-sedation instructions only, with no guided visualization.

    Behavioral: Standardized pre-sedation instructions only

  • Experimental
    Guided visualization and standardized pre-sedation instructions group

    This arm will receive standardized pre-sedation instructions, as well as one-minute guided visualization.

    Behavioral: Guided visualization and standardized pre-sedation instructions

Interventions

  • BehavioralGuided visualization and standardized pre-sedation instructions

    One arm will receive standardized pre-sedation instructions, as well as one-minute guided visualization.

  • BehavioralStandardized pre-sedation instructions only

    One arm will receive standardized pre-sedation instructions only.

06

What researchers measure

Primary outcomes

  1. Anesthesia Experience Survey

    A seven-point survey given after the patient meets Aldrete score discharge criteria, asking the following: how the patient rates their pre-operative anxiety level (0-10), if the patient has any recall of surgery (0 for none, 1 for a little, 2 for everything), if the patient remembers any pain during surgery (0 for none, 1 for a little, 2 for a lot), if the patient feels any nausea (0 for none, 1 for a little, 2 for a lot, 3 for vomiting), if the patient feels any pain now (0 for none, 1 for a little, 2 for a lot), if the patient feels any itching (0 for none, 1 for a little, 2 for a lot), and how satisfied the patient is overall with the sedation/anesthesia experience (0-10).

    Time frame: Within 2 hours of the completion of surgery

  2. Face-Legs-Activity-Cry-Consolability (FLACC)

    Face-Legs-Activity-Cry-Consolability (FLACC) is a behavioral scale primarily designed for scoring postoperative pain in infants and young children, but can also be used to assess intraoperative and postoperative pain in adults undergoing intravenous sedation. The scale gives 0, 1, or 2 points for each of the following: the appearance of the patient's face, the appearance of the patient's legs, the amount of activity, the presence of crying, and the extent of consolability, for a total of 10 points. 0-3 points corresponds to mild pain, 4-6 to moderate pain, and 7-10 to severe pain. The scores will be taken at three points in time during the anesthetic - during local anesthesia, during surgery, and fifteen minutes after surgery has concluded.

    Time frame: During local anesthesia, during surgery, and fifteen minutes after surgery has concluded

  3. Amount of medications used during the sedation

    The amount of each medication utilized during the sedation will be documented.

    Time frame: During the sedation

  4. Length of sedation

    The length of sedation will be measured, with the start point as the administration of the first sedative medication, and the endpoint as the end of phase I of anesthesia recovery, which will be determined with the Aldrete Scoring System.

    Time frame: During the sedation

07

Study locations

1 site
  • Oral & Maxillofacial Surgery Clinic, Highland Hospital, Alameda Health System
    Oakland, California 94602, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Apr 2026, 14 months.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 14 months is below that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 31, 2024
First posted
Jan 10, 2025
StartActual
Jan 2, 2025
Primary completionActual
Apr 1, 2026
CompletionActual
Apr 1, 2026
Last update
Apr 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06768021
Lead sponsor
Alameda Health System
Responsible party
Omid Akramian (Resident Surgeon, Alameda Health System) — Principal investigator
First posted
Jan 10, 2025
Start date
Jan 2, 2025
Primary completion
Apr 1, 2026
Completion
Apr 1, 2026
Last update
Apr 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion